PATIENT ADVISORY BOARD AGREEMENTPatient Advisory Board Agreement • November 1st, 2020
This Agreement (“Agreement”) is effective from the date of the last signature between Novartis Healthcare A/S (Reg. No. 20575786), Edvard Thomsens Vej 14, 2300 Köbenhavn S, Denmark (“Novartis”) and Patientforeningen Lungekræft (represented by Lisbeth Søbæk Hansen), Industrivej 21, 4000 Roskilde (“Patient”).
PATIENT ADVISORY BOARD AGREEMENTPatient Advisory Board Agreement • November 21st, 2018
This Agreement (“Agreement”) is entered into as of August 15th 2018 between Novartis Healthcare A/S (Reg. No. 20575786), Edvard Thomsens Vej 14, 2300 Köbenhavn S, Denmark (“Novartis”) and LYLE (Patientforeningen for Lymfekræft, Leukæmi og MDS) (represented by Leader Rita Christensen), Banetoften 26, 4700 Næstved, Denmark (“Patient”).
